María Koehler
- Oncology top 0.2%
- Pulmonary and Respiratory Medicine top 0.5%
- Cancer Research top 0.5%
- Molecular Biology top 5%
- Genetics top 0.5%
- Co-authors
- Cynthia Huang BartlettNicholas C. TurnerMassimo CristofanilliSherene LoiNadia HarbeckJungsil RoKe ZhangSunil Verma
- Topics
- HER2/EGFR in Cancer Research (37 papers)Advanced Breast Cancer Therapies (34 papers)Cancer Treatment and Pharmacology (24 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
María Koehler
109 papers receiving 6.8k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Oncology 5.0k
- Pulmonary and Respiratory Medicine 3.4k
- Cancer Research 1.9k
- Molecular Biology 1.5k
- Genetics 1000
Countries citing papers authored by María Koehler
This map shows the geographic impact of María Koehler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by María Koehler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites María Koehler more than expected).
Fields of papers citing papers by María Koehler
This network shows the impact of papers produced by María Koehler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by María Koehler. The network helps show where María Koehler may publish in the future.
Co-authorship network of co-authors of María Koehler
This figure shows the co-authorship network connecting the top 25 collaborators of María Koehler. A scholar is included among the top collaborators of María Koehler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with María Koehler. María Koehler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 3 | |
| 3 | 7 | |
| 4 | 4 | |
| 5 | 7 | |
| 6 | Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trialbreakdown → | 1247 |
| 7 | Phase III study of Palbociclib in combination with Exemestane vs. Capecitabine, in Hormonal Receptor (HR) positive/HER2 negative Metastatic Breast Cancer (MBC) patients with Resistance to non-steroidal Aromatase inhibitors (NSAI): PEARL study (GEICAM/2013-02_CECOG/BC.1.3.006) | 1 |
| 8 | 2 | |
| 9 | Randomized Study of Lapatinib Alone or in Combination With Trastuzumab in Women With ErbB2-Positive, Trastuzumab-Refractory Metastatic Breast Cancerbreakdown → | 701 |
| 10 | 114 | |
| 11 | 144 | |
| 12 | 345 | |
| 13 | 134 | |
| 14 | 4 | |
| 15 | 13 | |
| 16 | 4 | |
| 17 | 26 | |
| 18 | 2 | |
| 19 | The effects of long term methotrexate therapy on the gonadal function and morphology. | 1 |
| 20 | 11 |
About María Koehler
María Koehler is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hematology, having authored 112 papers that have together received 7.0k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (37 papers), Advanced Breast Cancer Therapies (34 papers) and Cancer Treatment and Pharmacology (24 papers). The work is most often cited by research in Oncology (5.0k citations), Cancer Research (1.9k citations) and Pulmonary and Respiratory Medicine (3.4k citations). María Koehler has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Cynthia Huang Bartlett, Nicholas C. Turner, Massimo Cristofanilli, Sherene Loi, Nadia Harbeck, Jungsil Ro, Ke Zhang, Sunil Verma, Hiroji Iwata and Fabrice André. Their work appears in journals such as New England Journal of Medicine, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.